Nath Bio-Genes Reports Mixed Financial Performance Amid Rising Interest Expenses
Nath Bio-Genes (India) has recently adjusted its evaluation following its financial performance for the quarter ending June 2025, which showed flat results. Key metrics include a record Net Sales of Rs 283.70 crore and a Debtors Turnover Ratio of 4.10 times, despite rising interest expenses.
Nath Bio-Genes (India), operating in the Other Agricultural Products sector, has recently undergone an evaluation adjustment that reflects notable shifts in its financial metrics. The company reported its financial performance for the quarter ending June 2025, which has been characterized as flat. This adjustment in evaluation has resulted in a revision of its score, moving from a previous position to a new one that indicates a change in its financial standing.Key metrics highlight the company's strengths, including a Debtors Turnover Ratio of 4.10 times, marking its highest performance to date. Additionally, the company achieved record figures in Net Sales at Rs 283.70 crore, PBDIT at Rs 38.29 crore, PBT less OI at Rs 34.12 crore, PAT at Rs 37.28 crore, and EPS at Rs 19.62. However, the company also faces challenges, notably a significant increase in interest expenses, which grew by 133.58% to Rs 3.20 crore.
Despite these mixed indicators, Nath Bio-Genes continues to navigate a competitive landscape, with its stock currently priced at Rs 193.60, reflecting a broader context of performance against market benchmarks.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
